People searching for an affordable way to lose weight with a GLP-1 drug may come across products marketed as “GLP-1 patches” online. They’re advertised as helping to reduce cravings, control appetite ...

Glucagon-like peptide-1 receptor agonists (GLP-1s) have become well known for their significant role as an aid in weight loss ...

GLP-1 weight loss patches reduced cravings during a month-long trial but caused no weight loss and remain unapproved by the FDA.

Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...

If you’re considering taking a GLP-1 (glucagon-like peptide-1) receptor agonist for weight loss, here’s what to know about the long-term benefits and risks, along with insights from physicians. GLP-1 ...

Anodyne Nanotech Inc., a clinical-stage biotechnology company simplifying chronic care through transdermal delivery, today ...

A record number of Americans are taking GLP-1 drugs for weight loss, according to a new Gallup survey released Tuesday — a massive increase over the past two years. According to the poll, 11 percent ...

GLP-1 use hits record high in the US, rising to 11% in 2026 amid falling obesity rates and expanded Medicare access programs.

Anodyne Nanotech announced today that it closed a $12.6 million Series A financing to support its transdermal drug delivery technology.

From ginger lozenges to psyllium fiber, these dietitian-approved products can help ease common digestive side effects while ...

Eligibility estimates contract from ~13.3 million with obesity/overweight to ~3.8 million Bridge-eligible Part D enrollees after excluding diabetes, OSA, MASH, and current GLP‑1 users. Modeled ...